Work

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: First results from STAMPEDE (MRC PR08, CRUK/06/019), a randomized controlled trial.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.5_suppl.26

Authors: Nicholas David James, Matthew Robert Sydes, Malcolm David Mason, Noel W Clarke, John Anderson, David Paul Dearnaley, John Dwyer, Gordana Jovic, Alastair SW Ritchie, J. Martin Russell, Karen Sanders, George Thalmann, Gianfilippo Bertelli, Alison J Birtle, Joe M. O'Sullivan, Andrew Protheroe, Denise Sheehan, Narayanan Srihari, Mahesh Parmar, STAMPEDE Investigators

Institutions: Institute of Cancer Research, Beatson West of Scotland Cancer Centre, Royal Hallamshire Hospital, Royal Marsden Hospital, The Christie NHS Foundation Trust, Cardiff University, University of Birmingham

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1742267199

Cites:

Cited by: 4

Related to: 10